Çalışma Alanları
- Sağlık Bilimleri Temel Alanı
- Farmasotik Kimya
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells, 2023
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors, 2022
- Drug Repurposing in Cancer Therapy: Approaches and Applications, ISBN: 0000000, 2020
- Drug Repurposing in Cancer Therapy: Approaches and Applications, ISBN: 0000000, 2020
- Drug Repurposing in Cancer Therapy: Approaches and Applications, ISBN: 0000000, 2020
- Drug Repurposing in Cancer Therapy: Approaches and Applications, ISBN: 0000000, 2020
- Drug Repurposing in Cancer Therapy: Approaches and Applications, ISBN: 0000000, 2020
- Postdoctoral Fellow, 1998
- Postdoctoral Scientist, 2000
- Visiting Professor, 2002
- Visiting Professor, 2003
- Visiting Scientist, 2003